Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-blind Cross-over Placebo-controlled Trial to Study the Impact on Behavioral and Psychological Symptoms of Dementia of Medical Cannabinoids (CBD/THC) in Patients with Severe Dementia in Long-term Care Facilities in Geneva

NCT05432206 is registered in ClinicalTrials.gov with Fondation pour l'accueil et l'hébérement des personnes âgées as lead sponsor.

NCT NCT05432206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-blind Cross-over Placebo-controlled Trial to Study the Impact on Behavioral and Psychological Symptoms of Dementia of Medical Cannabinoids (CBD/THC) in Patients with Severe Dementia in Long-term Care Facilities in Geneva
Lead sponsor
Fondation pour l'accueil et l'hébérement des personnes âgées
Phase
Phase 2/3
Overall status
Completed
Start date
September 29, 2023
Completion date
November 29, 2024
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with behavioral disturbance